CFD analysis was set up in the Fluent environment through the ANSYS platform.
In order to accelerate the product release process, a time optimized analytical HPLC analysis was set up (mobile phase: 60% NH4OAc buffer (0.2 M, pH 5.0), 40% CH3CN, flow rate: 1 mL/min, wavelength: 334 nm).
This analysis was set up in the pre-targeted therapy era.
A mobile unit for environmental analysis was set up, the Environmental analysis Van (EAV) or mobile umweltambulanz.
The cost analysis was set up from a societal perspective, which consists of three cost categories [ 11].
Polymerase chain reaction and restriction analysis were set up with the same biopsy used for the rapid urease test.
PCR conditions for semi-quantitative analysis were set up for each pair of primers to obtain non-saturated products.
The cut-off for considering a result to be statistically significant in the multivariate analysis was set up at p = 0.05.
High resolution melting (HRM) analysis was set up using 10 ng of genomic DNA, 3.5 mM MgCl2, 1× LightCycler 480 High Resolution Melting Master and 200 nM of each primer in a final reaction volume of 20 μl.
